This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2006.10.043v1 49/4/491    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Suzuki, J. Articles by Lew, W. Y.W. Search for Related Content PubMed PubMed Citation Articles by Suzuki, J. Articles by Lew, W. Y.W. Related Collections Related Article

Lipopolysaccharide Activates Calcineurin in Ventricular Myocytes

Jun Suzuki, MD, PhD^_*,, Evelyn Bayna, PhD^_*, Hai Ling Li, PhD^_*, Erminia Dalle Molle, BS^_*, and Wilbur Y.W. Lew, MD, FACC^_*,,_*

^_* Cardiology Section, Department of Medicine, V.A. San Diego Healthcare System, San Diego, California
University of California, San Diego, San Diego, California.

Manuscript received November 1, 2005; revised manuscript received August 31, 2006, accepted September 1, 2006.

^_* Reprint requests and correspondence: Dr. Wilbur Y. W. Lew, Cardiology Section 111A, V. A. San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, California 92161. (Email: wlew{at}ucsd.edu).

OBJECTIVES: We investigated whether lipopolysaccharide (LPS), a proximate cause of inflammation, activates calcineurin in cardiac myocytes and if calcineurin regulates apoptosis in this setting.

BACKGROUND: Calcineurin regulates myocardial growth and hypertrophy, but its role in inflammation is unknown. Calcineurin has proapoptotic or antiapoptotic effects depending on the stimuli.

METHODS: Calcineurin activity was measured in left ventricular myocytes from adult Sprague Dawley rats. Cardiac apoptosis was measured by terminal deoxy-nucleotidyl transferase-mediated dUTP nick end-labeling staining and caspase-3 activity after in vitro and in vivo exposure to LPS.

RESULTS: Lipopolysaccharide increased calcineurin activity in myocytes over 1 to 24 h (t 1/2 = 4.8 h) with an EC₅₀ of 0.80 ng/ml LPS (p < 0.05, n = 4). The LPS (10 ng/ml) effects were mimicked by angiotensin II (Ang II) (100 nmol/l); both increased calcineurin activity and induced apoptosis without additive effects (p < 0.05, n = 5 to 9). Lipopolysaccharide and/or Ang II effects were prevented by 1 h pre-treatment with an Ang II type 1 receptor blocker (losartan, 1 µmol/l), calcineurin inhibitor (cyclosporin A, 0.5 µmol/l), calcium chelator (1,2-Bis(2-amino-5-fluorophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl) ester, 0.1 µmol/l), or by inhibiting sarcoplasmic reticulum (SR) calcium (Ca)-ATPase (thapsigargin, 1 µmol/l) or SR calcium release channel (ryanodine, 1 µmol/l). Left ventricular apoptosis increased from 4 to 24 h after LPS (1 mg/kg intravenously) in vivo, but not in rats pre-treated with cyclosporin A (20 mg/kg/day subcutaneously) for 3 days (p < 0.05, n = 5).

CONCLUSIONS: In cardiac myocytes, LPS activates calcineurin in association with apoptosis by Ang II and SR calcium-dependent mechanisms. This expands the paradigm for cardiac calcineurin to be activated by low levels of LPS in inflammation and chronic conditions (e.g., infections, smoking, and heart failure).

Abbreviations and Acronyms   Ang II = angiotensin II   AT1 = angiotensin II type 1 receptor   BAPTA-AM = 1,2-Bis(2-amino-5-fluorophenoxy)ethane- N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl) ester   LPS = lipopolysaccharide   MPT = mitochondrial permeability transition pore   RyR = ryanodine receptor   SR = sarcoplasmic reticulum   TLR-4 = Toll-like receptor-4   TUNEL = terminal deoxy-nucleotidyl transferase-mediated dUTP nick end-labeling

Related Article

Sepsis, Calcineurin, and Cardiac Dysfunction: The Saga of Life and Death

Sabine Telemaque and Jawahar L. Mehta
J. Am. Coll. Cardiol. 2007 49: 500-501. [Full Text] [PDF]

This article has been cited by other articles:

				G. S. Di Marco, S. Reuter, D. Kentrup, L. Ting, L. Ting, A. Grabner, A. M. Jacobi, H. Pavenstadt, H. A. Baba, K. Tiemann, et al. Cardioprotective effect of calcineurin inhibition in an animal model of renal disease Eur. Heart J., August 1, 2011; 32(15): 1935 - 1945. [Abstract] [Full Text] [PDF]

				S. Telemaque and J. L. Mehta Sepsis, Calcineurin, and Cardiac Dysfunction: The Saga of Life and Death J. Am. Coll. Cardiol., January 30, 2007; 49(4): 500 - 501. [Full Text] [PDF]